title: Residual intraretinal retinoblastoma after chemoreduction failure.
authors.affiliation: Department of Ophthalmology, Emory University School of Medicine, Atlanta, GA 30322, USA.
authors.forename: Christopher K
authors.initials: CK
authors.lastname: Hwang
authors.forename: Thomas M
authors.initials: TM
authors.lastname: Aaberg
authors.forename: Patricia
authors.initials: P
authors.lastname: Chevez-Barrios
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Verner-Cole
authors.forename: Dan S
authors.initials: DS
authors.lastname: Gombos
authors.forename: Evelyn
authors.initials: E
authors.lastname: Paysse
authors.forename: Murali
authors.initials: M
authors.lastname: Chintagumpala
authors.forename: Weiqing
authors.initials: W
authors.lastname: Gao
authors.forename: Hans E
authors.initials: HE
authors.lastname: Grossniklaus
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage; D002675:Child, Preschool; D005047:Etoposide / Q000008:administration & dosage; D015353:Eye Enucleation; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D018365:Neoplasm, Residual; D019572:Retinal Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D012175:Retinoblastoma / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000473:pathology; D017211:Treatment Failure; D014463:Ultrasonography; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D005047:Etoposide; D016190:Carboplatin